Criteria for Selection
· Academic excellence
· Quality of the research project and training opportunity
· Relatedness of the project and training opportunity to the cancer research field
· Quality of the candidate
· Quality of the mentoring
· Evidence of the candidate’s research ability and potential
· Relatedness of the candidate’s career goals to cancer research
· Progress over the last year (for renewal applications ONLY)
Qualifications for Trainee Slots
- All appointments to this training grant are restricted to U.S. citizens and permanent residents.
- Applicants must be committed to cancer research.
- Predoctoral applicants must be enrolled in GPILS (PhD or MD/PhD program) at the University of Maryland Baltimore. Students must have completed the required courses: GPLS 790 - Advanced Cancer Biology and GPLS 665 - Cancer Biology: From Basic Research to the Clinic.
- An applicant may apply for an exception to this requirement. However, applicants may be required to take the course during the training period.
- Postdoctoral applicants must have completed doctoral level training (e.g. PhD, MD, MD/PhD, PharmD, DDS or equivalent). Evidence of scholarly productivity in the form of publications or planned publications is highly desirable. Trainees from clinical residence and fellowship training programs (e.g. Hematology/Oncology fellowship and Surgical residency programs) are encouraged to apply.
Research by Faculty Members
Below is a list of faculty members along with the focus on their research. Click the name of a faculty member to see their faculty profile. Faculty profiles include detailed information and contact information.
Adebamowo, Clement A., MD Sc.D
HPV associated cancers (cervical and head and neck cancer) and breast cancer
Adebamowo, Sally, MD Sc.D
Cervical and breast cancer epigenomics
Antalis, Toni, PhD
Regulation of proteolytic signaling pathways in cancer metastasis, and vascular biology
Baer, Maria, MD
Clinical and translational research in acute leukemias, myelodysplastic syndromes and myeloproliferative neoplasms.
Bromberg, Jonathan, MD, PhD
Lymphocyte migration, trafficking, lymphoid organ and structure, T cell immunity and T cell tolerance
Cao, Xuefang, MD, PhD
T cell biology, tumor immunity and transplantation immunity
Carrier, France, PhD
Genotoxic stress, cancer progression, and radiobiology
Civin, Curt, MD
Cell and molecular biology of normal hematopoiesis and leukemia
Dunning Hotopp, Julie C., PhD
Bacterial-animal lateral gene transfer; Integrations in the human cancer genome
Gaykalova, Daria, PhD
Head and neck cancer, HPV, chromatin, splicing
He, Xiaoming, PhD
Development of multiscale (micro-nano-macro) technologies for delivery of cancer therapeutic agents
Jay, Steven, PhD
Extracellular Vesicles; HER3-targeted protein therapeutics
Jewell, Christopher, PhD
Immune engineering; synthetic materials, nano-technology
Kim, Anthony, PhD
Development of translational nanomedicine for CNS diseases, brain cancers
Kontrogianni-Konstantopoulos, Aikaterini, PhD
Obscurins in skeletal & cardiac myopathies and tumor suppressor role in breast cancer
Krupnik, Alexander, MD
Development of new and novel mechanisms of immunosuppression for lung allografts and lung cancer immunotherapy, with an emphasis on natural killer cells.
Lin, Jiayuh, PhD
IL-6 signaling in meduloblastoma and triple negative breast cancer
Mackerell, Alexander D. Jr, PhD
Computational drug design: nucleic acids, proteins and carbohydrates
Martin, Stuart S., PhD
Cytoskeletal determinants of circulating breast tumor cell survival and metastasis
Melemedjian, Ohannes, PhD
Chemotherapy-induced mitotoxicity in sensory neurons
Montaner, Silvia, PhD, MPH
Molecular mechanisms associated with oral squamous cell carcinomas to identify molecular markers of disease progression and metastasis.
Njar, Vincent, PhD
Rational drug discovery of anti-cancer agents for breast, prostate and pancreatic cancers
O'Connor, Timothy, PhD
Effects of evolution and population structure on genomic architecture of cancer
Olson, John, MD, PhD
Mechanisms of tumor formation in primary hyperparathyroidism
Perkins, Darren, PhD
Anti-tumor immunity
Poulopoulos, Alexandros, PhD
In vivo CRISPR genome editing
Qi, Jianfei, PhD
Regulation of ubiquitin ligases and histone demethylases in prostate cancer
Qiu, Yun, PhD
Signal transduction by tyrosine kinases in prostate cancer progression
Rassool, Feyruz V., PhD
DNA damage and repair in cancer and leukemia
Rathinam, Chozha, PhD
Stem cell biology
Shen, Jana, PhD
Computer-aided drug design, Kinase drug delivery
Singh, Nevil, PhD
Immune activation, T cell tolerance; tumor immuno-therapy
Su, Lishan, PhD
Cancer immune therapy
Weber, David J., PhD
Structure and function of calcium-binding proteins, cancer biology and drug design
White, Ian, PhD
Extracellular vesicles and miRNA in cancer, biomarkers for early cancer diagnostics from liquid biopsies
Woodworth, Graeme, MD
Molecular mechanisms of glioblastoma margin (GBM); drug delivery by focused ultrasound
Zalzman, Michal, PhD
Control of telomere maintenance and cellular lifespan